Home » Authors » Christopher Delporte

Articles by Christopher Delporte

Life after DES: The search for the next blockbuster product

May 1, 2005

By Christopher Delporte

Leavitt outlines government’s ‘convenor’ role in healthcare IT

April 29, 2005

By Christopher Delporte

Stem cell research guidelines offered by National Academies

April 27, 2005

By Christopher Delporte

Panel hails Cardica’s PAS-Port but says more data is needed

April 26, 2005

By Christopher Delporte

AdvaMed: ‘significant changes’ produced by its ethics code

April 22, 2005

By Christopher Delporte

New AHRQ initiative could impact use of device therapies

April 19, 2005

By Christopher Delporte

Panel’s split decision leaves industry wondering what’s next

April 15, 2005

By Christopher Delporte

CMS funds back small-practice adoption of EHR technology

April 14, 2005

By Christopher Delporte

Inamed falls short in its bid to lift the FDA’s ban on product

April 14, 2005

By Christopher Delporte

By a 7-2 vote, Mentor earns an ‘approvable’ recommendation

April 14, 2005

By Christopher Delporte

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...